ArticleJournal of neurology2026

DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.

Bertrand Bourre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.